Investigating low vulnerability of the posterior eye segment to SARS-CoV-2

Video

Steffen E. Künzel, MD, discusses the key points of his research presentation regarding low vulnerability of the posterior eye segment to SARS-CoV-2 infection.

Steffen E. Künzel, MD, from the Department of Ophthalmology Charité University Medicine Berlin, Berlin, Germany, discusses the key points of his research presentation on low vulnerability of the posterior eye segment to SARS-CoV-2 infection during the virtual 2021 ARVO meeting.

See more ARVO content

Newsletter

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Recent Videos
Victor Gonzalez, MD, speaks about his Clinical Trials at the Summit presentation, focusing on retinitis pigmentosa therapy MCO-010 (Nanoscope Therapeutics)
Carl Danzig, MD, director of vitreo-retinal services at the Rand Eye Institute in Deerfield Beach, Florida, shared an update on his research in OCS-01 drops for diabetic macular edema during ARVO
© 2025 MJH Life Sciences

All rights reserved.